MD Anderson/Rice Cancer Nanotech T32
About the Program
The goal of this program is to train scientists who will transfer the great promise of nanotechnology into clinical reality. This novel training program educates future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, who are keenly aware of the needs and demands of clinical environment as well as of major challenges of translational research.
Our T32 program is based on a partnership between Rice and MD Anderson investigators who have strong interests in nanotechnology and translational cancer research. These two institutions are home to some of the most active basic research on nanoparticles and nanotechnology in the world as well as some of the most innovative clinical translational research in cancer. There is a natural alignment and complementarity of interests between Rice University, which provides the technological infrastructure and intellectual leadership in bioengineering, physics and chemistry, and MD Anderson Cancer Center, which provides a clinical base for translational research in cancer imaging and therapy. Physically, these centers of excellence in their respective realms are located within a mile from each other, and recent years have seen concerted efforts to facilitate, nurture, and galvanize interdisciplinary translational interactions between investigators and students at these campuses.
Our program has two tiers: a predoctoral program for training Ph.D. and a postdoctoral program
The Predoctoral Program - provides mentorship, training, and funding for 2-3 years to students who have been accepted into (i) the Ph.D. program in Bioengineering or Chemistry, at Rice University, and (ii) the Graduate School of Biomedical Sciences (GSBS) at MD Anderson.
Postdoctoral Program - will provide fellowships to recent Ph.D. awardees for 2-3 years with training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology. Holders of an M.D. degree will be eligible for the program if they show a strong interest in translational cancer nanotechnology research.
This training program includes multidisciplinary, hands-on coursework, seminar experiences, and multidisciplinary mentorship of translational research projects.
Shared laboratory facilities and equipment provide program fellows with an outstanding research environment that combines state-of-the-art instrumentation, facilities for animal research, and vast opportunities to be an integral part of clinical trials.
The program includes a total of 34 faculty mentors from MD Anderson Cancer Center (16 mentors) and Rice University (18 mentors). Each fellow will be co-mentored by two program faculty (one from MD Anderson and one from Rice), with one faculty member having a supervisory and the other a co-supervisory role. The major research training activities will be carried out at the campus location of the primary mentor.
Eligibility Requirements
Per T32 program requirement, fellows “must be citizens or a noncitizen nationals of the United States or have been lawfully admitted for permanent residence at the time of appointment.”
MD Anderson Applications
Apply Here
A T32 Training Program in Translational Cancer Nanotechnology funds the 2 years pre-doctoral fellow position.
The program is geared toward young scientists pursuing integrated; translational research focused on advancing promising new nanoscience-based technologies to improve cancer care. The fellows will commit much of their time to research and technical training. The research projects will be clinically and biologically relevant to cancer and examine nanoscience and nanotechnology as potential solutions. A detailed mentoring plan will be developed for each fellow that includes research project aims, multidisciplinary coursework, and seminar experiences.
Learning Objectives
The main goal of this T32 training program is to educate future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, which are keenly aware of the needs and demands of a clinical environment and the major challenges of translational research. After completing this program, the trainees will be able to demonstrate the ability to carry out independent translational research in cancer nanotechnology. Didactic coursework will prepare them to contribute to research projects that directly address barriers to the translation of nanotechnology-based approaches and to develop the skills needed to define and lead such projects. Trainees will gain essential writing skills through scientific writing seminars and by writing an NIH grant proposal. Further, trainees will gain critical lab management skills by participating in a short hands-on course introducing laboratory and project management.The main goal of this T32 training program is to educate future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, which are keenly aware of the needs and demands of a clinical environment and the major challenges of translational research. After completing this program, the trainees will be able to demonstrate the ability to carry out independent translational research in cancer nanotechnology. Didactic coursework will prepare them to contribute to research projects that directly address barriers to the translation of nanotechnology-based approaches and to develop the skills needed to define and lead such projects. Trainees will gain essential writing skills through scientific writing seminars and by writing an NIH grant proposal. Further, trainees will gain critical lab management skills by participating in a short hands-on course introducing laboratory and project management.
Eligibility Requirements
Must have been accepted into (i) the Ph.D. program in Bioengineering or Chemistry, at Rice University, and (ii) the Graduate School of Biomedical Sciences (GSBS) at MD Anderson.
Per NIH T32 program requirement, fellows "must be citizens or noncitizen nationals of the United States or have been lawfully admitted for permanent residence at the time of appointment."
Position Salary Information
This position will provide a salary between $15,500 - $37,000
Additional Application Information
After completing the application, please email the following documents to T32_MDA_Rice@mdanderson.org.
Letter from Ph.D. thesis advisor, Up to 3-pages proposal describing a research project with focus on cancer nanotechnology, and Current CV.
Facutly Mentor
Dr. Konstantin Sokolov
The postdoctoral fellow position is part of a T32 Training Program partnership between UT MD Anderson Cancer Center and Rice University.
The program is geared toward young scientists who aim to pursue integrated; translational research focused on advancing promising new nanotechnology-based diagnostics and therapeutics to improve cancer care. The fellows will commit much of their time to research and technical training, with the course participation accounting for no more than 10% of their effort. The research projects will be clinically and biologically relevant to cancer and will examine nanoscience and nanotechnology as potential solutions. A detailed mentoring plan will also be developed for each fellow that includes project aims and multidisciplinary coursework, and seminar experiences.
Learning Objectives
The main goal of this T32 training program is to educate future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, which are keenly aware of the needs and demands of a clinical environment and the major challenges of translational research. After completing this program, the trainees will be able to demonstrate the ability to carry out independent translational research in cancer nanotechnology. Didactic coursework will prepare them to contribute to research projects that directly address barriers to the translation of nanotechnology-based approaches and to develop the skills needed to define and lead such projects. Trainees will develop a foundational background in the field by taking at least four didactical courses related to translational cancer or nanotechnology topics. Trainees will gain essential writing skills through scientific writing seminars and by writing an NIH grant proposal. Finally, trainees will gain critical lab management skills by participating in a short hands-on course introducing laboratory and project management.
Eligibility Requirements
Per the T32 program requirement, qualified postdoctoral fellows "must be citizens or noncitizen nationals of the United States or have been lawfully admitted for permanent residence at the time of appointment."
Candidates should have recently completed (within three years) Ph.D. training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology. Holders of an M.D. degree will be eligible for the program if they show a strong interest in translational cancer nanotechnology research.
Preferred Experience: Candidates with training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology. Candidates with M.D. degrees may be eligible for the program if they show a strong interest in translational cancer nanotechnology research.
Position Information
MD Anderson offers full-time postdoc positions with a salary ranging from $64,000 to $76,000. depending on the number of years of postgraduate experience. MD Anderson trainee compensation also includes:
-Paid medical benefits (zero premium) starting on the first day for trainees who work 30 or more hours per week
-Group dental, vision, life, AD&D, and disability coverage
-Paid education, vacation, and sick leave
-Paid institutional holidays, wellness leave, childcare leave, and other paid leave programs
-Teachers Retirement System defined-benefit pension plan and two voluntary retirement plans
-Employer-paid life, AD&D, and an illness-related reduced salary pay program
-Health Savings Account and Dependent Care Reimbursement flexible spending accounts
-Fertility benefits
-State of Texas longevity pay
-Extensive wellness, fitness, employee health programs, and employee resource groups.
Additional Application Information
Applicants must include their GPA on their CV to be considered for this position
After completing the application, please email the following documents to T32_MDA_Rice@mdanderson.org.
Up to 2 pages research interest statement with names of preferred MD Anderson Cancer Center or Rice faculty mentors, Current CV and Names of 3-5 references.
Faculty Mentor
Dr. Konstantin Sokolov
Our Labs
Learn more about our faculty and research taking place in our labs.
Conferences
View conferences available for continuing education credit.